\-\ Texto\\:\\ \ \(0\)\
\-\ surgical\\ resection\\ curative\\.\\ nsaids\\ or\\ steroids\\ to\\ calm\\ inflammation\\ in\\ cases\\ of\\ rupture\ \(0\)\
\-\ well\\ circumscribed\\ mass\\ within\\ the\\ left\\ lacrimal\\ fossa\\ which\\ follows\\ fat\\ signal\\ intensity\\ on\\ all\\ sequences\\.\ \(0\)\
\-\ orbital\\ dermoid\ \(1\)\
\-\ ddx\\ for\\ lacrimal\\ gland\\ lesion\\:\ \(0\)\
\-\ more\\ common\\ \\(abscess\\/hematoma\\,\\ orbital\\ pseudotumor\\,\\ lymphoma\\,\\ lacrimal\\ benign\\ mixed\\ tumor\\)\ \(0\)\
\-\ less\\ common\\ \\(dermoid\\ cyst\\,\\ sarcoid\\,\\ sjogren\\ syndrome\\,\\ adenoid\\ cystic\\ carcinoma\\,\\ pleomorphic\\ adenoma\\)\\.\ \(0\)\
\-\ 26\\ yo\\ male\\ with\\ chronic\\ diffuse\\ headache\\,\\ incidental\\ left\\ orbital\\ finding\\ is\\ noted\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lacrimal\\:\\ 0\\.19840180058224455\ \(0\)\
\-\ orbital\\:\\ 0\\.13818219849438892\ \(0\)\
\-\ abscess\\/hematoma\\:\\ 0\\.10017634572689203\ \(0\)\
\-\ calm\\:\\ 0\\.09229967322052901\ \(0\)\
\-\ dermoid\\:\\ 0\\.08853494313950848\ \(0\)\
\-\ sjogren\\:\\ 0\\.07806373039671802\ \(0\)\
\-\ adenoid\\:\\ 0\\.06866965570143997\ \(0\)\
\-\ curative\\:\\ 0\\.0650508633023657\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.05618542514839327\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.05463846862197758\ \(0\)\
\-\ nsaids\\:\\ 0\\.052395747779267414\ \(0\)\
\-\ follows\\:\\ 0\\.05222739453170899\ \(0\)\
\-\ ddx\\:\\ 0\\.05126651512229918\ \(0\)\
\-\ common\\:\\ 0\\.05082425481719084\ \(0\)\
\-\ sarcoid\\:\\ 0\\.049826154830945275\ \(0\)\
\-\ steroids\\:\\ 0\\.04567872589056542\ \(0\)\
\-\ 26\\:\\ 0\\.044951204768236656\ \(0\)\
\-\ circumscribed\\:\\ 0\\.04316180212672243\ \(0\)\
\-\ mixed\\:\\ 0\\.04264685671522195\ \(0\)\
\-\ gland\\:\\ 0\\.041356462402189424\ \(0\)\
\-\ inflammation\\:\\ 0\\.04129244174630015\ \(0\)\
\-\ rupture\\:\\ 0\\.0412287797514289\ \(0\)\
\-\ sequences\\:\\ 0\\.040551072179613776\ \(0\)\
\-\ adenoma\\:\\ 0\\.040551072179613776\ \(0\)\
\-\ fossa\\:\\ 0\\.03957726853069465\ \(0\)\
\-\ incidental\\:\\ 0\\.03677032497704859\ \(0\)\
\-\ intensity\\:\\ 0\\.03509853041340115\ \(0\)\
\-\ benign\\:\\ 0\\.033511935989013655\ \(0\)\
\-\ headache\\:\\ 0\\.03335210724506589\ \(0\)\
\-\ less\\:\\ 0\\.03288568186730321\ \(0\)\
\-\ cases\\:\\ 0\\.03235012345433105\ \(0\)\
\-\ finding\\:\\ 0\\.03129615346634638\ \(0\)\
\-\ resection\\:\\ 0\\.030283132449093395\ \(0\)\
\-\ fat\\:\\ 0\\.02953309457820038\ \(0\)\
\-\ diffuse\\:\\ 0\\.029397811595174034\ \(0\)\
\-\ yo\\:\\ 0\\.02921990367389502\ \(0\)\
\-\ cystic\\:\\ 0\\.02800718985513362\ \(0\)\
\-\ syndrome\\:\\ 0\\.027771665644711837\ \(0\)\
\-\ lymphoma\\:\\ 0\\.02775225720897143\ \(0\)\
\-\ carcinoma\\:\\ 0\\.027521905341089392\ \(0\)\
\-\ all\\:\\ 0\\.027465039652628306\ \(0\)\
\-\ chronic\\:\\ 0\\.027352154919397728\ \(0\)\
\-\ cyst\\:\\ 0\\.026095126545751166\ \(0\)\
\-\ signal\\:\\ 0\\.025603117389463394\ \(0\)\
\-\ \\,\\:\\ 0\\.024610005956117034\ \(0\)\
\-\ more\\:\\ 0\\.02428609442400189\ \(0\)\
\-\ noted\\:\\ 0\\.023016149868779475\ \(0\)\
\-\ tumor\\:\\ 0\\.022639003427395582\ \(0\)\
\-\ well\\:\\ 0\\.0219668290110074\ \(0\)\
\-\ left\\:\\ 0\\.021729665210748064\ \(0\)\
\-\ surgical\\:\\ 0\\.0204116110255847\ \(0\)\
\-\ lesion\\:\\ 0\\.019779036659096076\ \(0\)\
\-\ within\\:\\ 0\\.018524220549841836\ \(0\)\
\-\ which\\:\\ 0\\.018126643036847145\ \(0\)\
\-\ male\\:\\ 0\\.017559153839630377\ \(0\)\
\-\ \\(\\:\\ 0\\.01641731196008774\ \(0\)\
\-\ \\)\\:\\ 0\\.016216765729847843\ \(0\)\
\-\ mass\\:\\ 0\\.013505238715313233\ \(0\)\
\-\ \\:\\:\\ 0\\.012844031999893922\ \(0\)\
\-\ or\\:\\ 0\\.011380940329133041\ \(0\)\
\-\ for\\:\\ 0\\.008285319870939944\ \(0\)\
\-\ on\\:\\ 0\\.00822603423142532\ \(0\)\
\-\ is\\:\\ 0\\.006389667936190064\ \(0\)\
\-\ to\\:\\ 0\\.004853046686852117\ \(0\)\
\-\ in\\:\\ 0\\.004788604887957443\ \(0\)\
\-\ \\.\\:\\ 0\\.0016136152771521035\ \(0\)\
\-\ the\\:\\ 0\\.0015710145989048386\ \(0\)\
\-\ with\\:\\ 0\\.0013295929101123833\ \(0\)\
\-\ of\\:\\ 0\\.0013239068272498686\ \(0\)\
